Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Termination of appointment of Howard Mayer as a director on 2026-04-01
Appointment of Guenaelle Levoir as a director on 2026-04-01
Termination of appointment of Michele Ollier as a director on 2025-12-05
Termination of appointment of Paul Sekhri as a director on 2025-10-01
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
30/09/2026Filing deadline
Confirms the registry record is up to date
The latest figures KAERUS BIOSCIENCE LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £2.08M
Total Assets
2023: £2.67M
Cash in Bank
2023: £2.48M
Total Liabilities
2023: £597.90K
Employees
2023: 5
Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 19.65% on 2023. See the full financial analysis for KAERUS BIOSCIENCE LIMITED.
The full financial record
Four ways through KAERUS BIOSCIENCE LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 6 | +1 |
| 2023 | 5 | 0 |
| 2022 | 5 | +1 |
| 2021 | 4 | – |
Reported employee count increased from 4 in 2021 to 6 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 17/08/2022–02/05/2024 | 0 | |
| Corporate Secretary | 12/07/2016–03/12/2017 | 49 | |
| Director | 25/06/2021–Present | 32 | |
| Director | 22/05/2019–14/07/2021 | 2 | |
| Director | 12/07/2016–05/12/2025 | 4 | |
| Director | 09/02/2021–06/10/2023 | 2 | |
| Director | 29/06/2021–26/04/2023 | 0 | |
| Director | 21/04/2017–19/07/2021 | 0 | |
| Director | 12/03/2019–Present | 0 | |
| Director | 06/10/2023–01/10/2025 | 0 | |
| Director | 02/05/2024–01/04/2026 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 19/10/2018–Present | 0 |
Every document on the Companies House record, newest first.
Termination of appointment of Howard Mayer as a director on 2026-04-01
Appointment of Guenaelle Levoir as a director on 2026-04-01
Termination of appointment of Michele Ollier as a director on 2025-12-05
Termination of appointment of Paul Sekhri as a director on 2025-10-01
Statement of capital on 2025-10-02
Statement by Directors
Resolutions
Solvency Statement dated 30/09/25
Total exemption full accounts made up to 2024-12-31
Director's details changed for Mr Francesco De Rubertis on 2025-07-11
Confirmation statement made on 2025-07-11 with updates
Statement of capital following an allotment of shares on 2024-10-01
Showing 12 of 42 filings
See when the next accounts and confirmation statement are due
84 UK companies are similar to KAERUS BIOSCIENCE LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
Allia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
The Lexicon Second Floor, Mount Street, Manchester M2 5NT
Spitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
76 Portland Place, London W1B 1NT
A short description of the company, written from its Companies House record.
KAERUS BIOSCIENCE LIMITED is a private limited company registered in the United Kingdom, based in 2nd Floor 168 Shoreditch High Street, London E1 6RA. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 10 years 2 months.
The register currently records it as active. Its 2024 accounts report net assets of £1.83M and 6 employees.
Answered from this company's own registry record and filed figures.
Companies House records KAERUS BIOSCIENCE LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
KAERUS BIOSCIENCE LIMITED is recorded as active on the Companies House register, and has been on it since 12/07/2016.
The most recent accounts Okredo holds cover 2024 and report net assets of £1.83M, total assets of £2.15M, cash in bank of £2.06M and total liabilities of £316.97K.
The most recent document on the record is dated 16/04/2026: Termination of appointment of Howard Mayer as a director on 2026-04-01, 5 months ago.
On the current registry record, accounts are due by 30/09/2026.
Companies House lists 11 officers (2 currently in post) and 1 person with significant control.